Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →
A pharma formulator dispatching HSN 3004 formulations to distribution partners across the 22-September-2025 rate cutover faces a Section 14 CGST time-of-supply exposure on every invoice issued in the 21-30 September 2025 pipeline window. An invoice raised on 21-September-2025 at 12 percent for goods that are physically dispatched on 23-September-2025 and received at the distributor on 24-September-2025 falls under Section 14 Clause (b)(i) — supply made after the rate change, invoice issued prior, payment received after — and the applicable rate is the new 5 percent, not the 12 percent charged on the original invoice. Absent correction, either the supplier over-collects and over-remits 7 percentage points of GST that Section 14 does not permit, or the distributor claims ITC at 12 percent that Section 14 caps at 5 percent, exposing the distributor to a Section 73 or Section 74 demand at the next GSTR-2B or GSTR-3B scrutiny. Thousands of pipeline invoices in the pharma channel in the 21-30 September 2025 window are potentially affected.
Extract every invoice issued between 21-September-2025 and 30-September-2025 from the supplier's ERP invoice register. For each invoice, cross-reference three date fields: the invoice date (from the ERP), the dispatch date (from the transporter's lorry receipt or the e-way bill), and the goods-received-date (from the distributor's goods-received-note where available, or the delivery-confirmation event from the transporter). Anchor the supply date to the dispatch date under Section 31 read with Rule 46, and classify the invoice against Section 14: Clause (a)(ii) if dispatch was before 22-September-2025 with invoice-and-payment sequence matching, or Clause (b)(i) if dispatch was on or after 22-September-2025 with invoice issued prior to and payment received after the cutover. Derive the applicable rate from the classification. Where the applicable rate diverges from the rate charged on the original invoice, generate a Section 34 credit note reversing the original tax charge and issue a fresh tax invoice at the corrected rate for the same taxable value and quantity. Feed the credit note into the supplier's GSTR-1 for the correct tax period and reconcile the flow into the distributor's GSTR-2B and GSTR-3B ITC claim.
Invoice master keyed on invoice number, invoice date, supplier GSTIN, recipient GSTIN, HSN code, taxable value, rate charged, and tax amount; e-way bill and lorry-receipt master keyed on invoice reference with dispatch date, transporter identifier, and vehicle registration; distributor goods-received-note master keyed on invoice reference with receipt date and receipt-quantity confirmation; Section 14 clause-classification rulebook keyed on the dispatch-date test (before vs on-or-after 22-September-2025) and the invoice-and-payment sequence; Section 34 credit-note template with mandatory fields per Rule 53 (original invoice reference, credit-note number, credit-note date, reason code, differential taxable value or tax component); GSTR-1 upload feed and GSTR-2B download feed keyed on supplier GSTIN and recipient GSTIN for the corresponding tax periods; distributor ITC reversal register with per-invoice ITC-eligibility flag and the Section 14 clause that governs the position.
A month-end straddle-invoice reconciliation pack for the 21-30 September 2025 window: full invoice inventory extract with dispatch date, receipt date, and Section 14 clause classification per invoice; Section 34 credit-note issuance schedule with reason codes and GSTR-1 period assignment; fresh invoice issuance schedule at the corrected rate matched one-to-one to the reversed original invoices; distributor-side ITC reversal register with the ITC-eligibility position, the applicable rate cap, and any GSTR-2B versus GSTR-3B differential to be flagged with the supplier; and an audit trail per invoice that a Section 65 audit team or a Section 61 scrutiny officer can walk from the original invoice through the Section 14 classification, the Section 34 credit note, the fresh invoice, and the ITC claim on both sides of the transaction.
An Aurobindo Formulations dispatch team at Unit-IV Hyderabad closes the September 2025 books with a pipeline of formulation invoices spread across the 21-30 September dispatch window — HSN 3004 medicaments in measured doses for retail sale, moving to distribution partners across Chennai, Bengaluru, Mumbai, and Kolkata. On the 21-September-2025 invoice register, every line was raised at 12 percent — the prevailing formulation rate. On 22-September-2025, the 56th GST Council rate rationalisation took effect and the flat 5 percent pharma rate replaced the earlier 12 percent for all drugs. Between the invoice raised on 21-September and the goods received at the Chennai distributor on 24-September sit three days of transit and one Section 14 time-of-supply question. This is straddle invoice pharma pre post 22 September 2025 Section 14 time of supply at the operating scale of an Indian formulator, and the discipline that closes the straddle window cleanly is what separates a formulator whose Section 65 audit walks in a straight line from one that spends the following two quarters reconciling GSTR-2B mismatches at every distributor.
Quick reference
| Aspect | Detail |
|---|---|
| Governing time-of-supply section | Section 14 CGST Act 2017 (change in rate of tax) |
| Trigger event | 56th GST Council rate rationalisation effective 22-September-2025 |
| Pre-cutover rate on HSN 3004 formulations | 12 percent |
| Post-cutover rate on HSN 3004 formulations | 5 percent |
| Section 14 Clause (a)(ii) | Supply pre-change, invoice pre-change, payment post-change → invoice date → old rate |
| Section 14 Clause (b)(i) | Supply post-change, invoice pre-change, payment post-change → payment date → new rate |
| Correction mechanism | Section 34 CGST credit note + fresh invoice at corrected rate |
| Section 34 credit-note window | 30 November of following financial year or annual return date, whichever earlier |
| Credit-note flow | Supplier GSTR-1 → recipient GSTR-2B → recipient GSTR-3B ITC reversal |
| Anchoring evidence for supply date | Transporter lorry receipt / e-way bill / goods-received-note |
| Pharma channel exposure | Thousands of pipeline invoices in the 21-30 September window |
The reconciliation in one paragraph
A pharma formulator’s straddle-invoice reconciliation for the 22-September-2025 rate cutover works on a three-date-per-invoice foundation. Invoice date from the ERP, dispatch date from the transporter’s lorry receipt or the e-way bill, and goods-received-date from the distributor’s own goods-received-note. Section 31 CGST read with Rule 46 anchors the supply date to the point of removal of goods — the dispatch date — for a supply of goods. Section 14 CGST then bifurcates every invoice in the 21-30 September window into one of six clauses based on whether the supply was made before or after 22-September-2025 and on the sequencing of the invoice and payment dates around the cutover. Where the resulting time-of-supply position fixes the applicable rate at a value different from the rate charged on the original invoice, Section 34 authorises the supplier to issue a credit note reducing the tax charged, and the supplier issues a fresh invoice at the corrected rate. The credit note reports in the supplier’s GSTR-1 for the tax period, auto-flows into the recipient distributor’s GSTR-2B, and drives the distributor’s ITC reversal in GSTR-3B. The recipient distributor maintains a per-invoice ITC reversal register that carries the Section 14 clause, the applicable rate, and the ITC-eligibility position, and that register is the audit trail for any subsequent Section 61 scrutiny or Section 65 audit of the straddle window.
What the scenario looks like in India
The straddle-invoice scenario sits inside the standard formulator-to-distributor supply chain that most Indian pharma companies operate. A formulator such as Aurobindo Pharma at Unit-IV Hyderabad, Sun Pharmaceutical Industries at Halol in Gujarat, Dr Reddy’s Laboratories at Bachupally in Hyderabad, Cipla at Kurkumbh in Maharashtra, Lupin at Ankleshwar in Gujarat, Zydus Lifesciences at Ahmedabad, Torrent Pharmaceuticals at Ahmedabad, Alkem Laboratories, Glenmark Pharmaceuticals, Ipca Laboratories, Ajanta Pharma, or Cadila Pharmaceuticals raises tax invoices at the finished-formulation dispatch depot when the picking sheet is closed and the shipment is ready for handoff to the transporter. In many depots the invoicing happens a few hours before the vehicle actually leaves the loading bay; in high-volume depots the invoicing can happen the previous evening on the following-day dispatch plan. Once the vehicle rolls, an e-way bill is generated on the CBIC e-way bill portal for consignments over the state threshold, the lorry receipt is issued by the transporter, and the shipment enters transit. Transit time from a Hyderabad formulation plant to a Chennai distributor is typically 2 to 3 days by road; to a Mumbai distributor 2 days; to a Kolkata distributor 3 to 4 days. The distributor’s warehouse receives the shipment, conducts inward quality-hold and receipt verification, and files a goods-received-note on the same day or the day after.
The 22-September-2025 rate cutover therefore cuts across this natural 2-to-4-day dispatch-to-receipt window. Every invoice raised in the 20-25 September range is potentially a straddle invoice — either because the dispatch date and the invoice date do not coincide, or because the dispatch date and the receipt date fall on different sides of the cutover. A formulator issuing a full-week dispatch schedule with an invoice date of 21-September-2025 at 12 percent may find on the transporter’s lorry receipt that the vehicle rolled at 23:00 on 21 September, reached the state border at 08:00 on 22 September, and reached the distributor’s warehouse at 14:00 on 24 September. Depending on the specific classification of the “supply” moment under Section 14, the applicable rate is either the old 12 percent or the new 5 percent, and the correction path — Section 34 credit note or no correction — follows from that classification.
The regulatory overlay — Section 14 CGST, Section 34 credit note, and the 56th Council transition
Three regulatory anchors together govern the straddle-invoice reconciliation, and each maps to a specific working control.
Section 14 of the Central Goods and Services Tax Act 2017 is the operative time-of-supply section where there is a change in the rate of tax. It overrides Sections 12 and 13 (the general time-of-supply provisions for goods and for services respectively) and bifurcates every straddle transaction into one of six clauses. Clause (a) covers supplies made BEFORE the change in rate and contains three sub-clauses: (i) where both invoice and payment are received AFTER the change — time of supply is the earlier of invoice or payment; (ii) where invoice was issued PRIOR to the change but payment is received AFTER — time of supply is the date of invoice; (iii) where payment was received BEFORE the change but invoice is issued AFTER — time of supply is the date of payment. Clause (b) covers supplies made AFTER the change in rate and contains three parallel sub-clauses: (i) where invoice was issued PRIOR to the change but payment is received AFTER — time of supply is the date of payment; (ii) where both invoice and payment happened BEFORE — time of supply is the earlier of the two; (iii) where invoice is issued AFTER but payment was received BEFORE — time of supply is the date of invoice. The rate applicable at the time of supply governs the transaction.
For a supply of goods, the “supply” moment is anchored to the removal of goods from the supplier’s premises per Section 31 read with Rule 46, which obliges the supplier to issue the tax invoice before or at the time of removal. In practice, the dispatch date on the transporter’s lorry receipt and the e-way bill is the strongest evidentiary anchor for the supply moment. Where the dispatch date is before 22-September-2025, Clause (a) governs; where the dispatch date is on or after 22-September-2025, Clause (b) governs. An invoice issued on 21-September-2025 in anticipation of a dispatch that only rolled on 23-September-2025 falls under Clause (b)(i) — supply post-change, invoice pre-change, payment post-change — and the time of supply is the payment date at the new 5 percent rate. An invoice issued on 21-September-2025 for goods that actually rolled the same evening and arrived on 24-September falls under Clause (a)(ii) — supply pre-change, invoice pre-change, payment post-change — and the time of supply is the invoice date at the old 12 percent rate.
Section 34 of the CGST Act 2017 authorises the supplier to issue a credit note where the tax charged on the original invoice exceeds the tax payable at the correct time of supply. The credit note references the original invoice number and date, reduces the tax charged by the differential (7 percentage points on the base value where a 12 percent invoice must be corrected to 5 percent), and is reported in the supplier’s GSTR-1 for the tax period. The reduction flows into the recipient’s GSTR-2B and the recipient reverses the corresponding ITC in GSTR-3B for the period. A fresh tax invoice is then issued at the corrected rate for the same taxable value and quantity, and that invoice generates fresh ITC for the recipient. The Section 34 window closes on 30 November of the following financial year or the date of the annual return, whichever is earlier — so the correction for a 21-September-2025 straddle invoice must be reported by 30-November-2026 at the latest.
The 56th GST Council meeting on 3-September-2025, with the rate rationalisation effective 22-September-2025, is the trigger event. The Council FAQ (specifically Q10 and Q25) provides the transitional guidance for pipeline invoices and stock-in-hand at the cutover — the 56th GST Council pharma rate transition walkthrough covers the Council FAQ in detail, and the GST Council FAQ reading guide reads Q10, Q25, and Q51 as an operating manual for the pharma transition.
A worked example — an Aurobindo Formulations Unit-IV straddle pipeline
Illustrative — the following figures represent the operating pattern of a Tier-1 formulator’s dispatch pipeline of the scale that runs from Hyderabad-Vishakhapatnam plants to distribution partners across South India. Public disclosures do not reveal per-invoice dispatch and receipt detail; cross-verify against your ERP invoice register, e-way bill portal, and distributor GRN feed before action.
Aurobindo Formulations Unit-IV Hyderabad closes its September 2025 formulation dispatch pipeline with 4,200 invoices issued between 21-September-2025 and 30-September-2025, aggregating Rs 186 crore in taxable value across HSN 3004 formulation SKUs to 340 distribution partners. Of the 4,200 invoices, 620 carry an invoice date of 21-September-2025 at the old 12 percent rate. The transporter lorry-receipt and e-way bill extract shows that of these 620 pre-cutover-dated invoices, 380 had a dispatch date on or before 21-September-2025 (goods physically rolled pre-cutover), and 240 had a dispatch date of 22-September-2025 or later (invoice raised in anticipation, dispatch deferred).
For the 380 pre-cutover-dispatch invoices, Section 14 Clause (a)(ii) applies — supply pre-change, invoice pre-change, payment post-change — and time of supply is the invoice date. Applicable rate is 12 percent. The original invoice stands; no correction required. Aggregate taxable value on this leg is Rs 118 crore, GST charged and payable Rs 14.16 crore.
For the 240 post-cutover-dispatch invoices, Section 14 Clause (b)(i) applies — supply post-change, invoice pre-change, payment post-change — and time of supply is the date of receipt of payment (which for a distributor operating on standard credit terms falls comfortably after 22-September-2025). Applicable rate is 5 percent. The original invoice was raised at 12 percent and must be corrected. The dispatch team issues 240 Section 34 credit notes reversing the original 12 percent tax charge (Rs 8.6 crore on aggregate taxable value of Rs 72 crore) and issues 240 fresh tax invoices at 5 percent for the same taxable value (Rs 3.6 crore of GST on Rs 72 crore). Net correction: Rs 5 crore of GST refunded to the distribution channel through the credit-note-and-fresh-invoice pair, and the distributor’s ITC claim across the channel is reset from Rs 8.6 crore to Rs 3.6 crore in the same GSTR-3B period. The Section 34 credit notes are reported in Aurobindo’s GSTR-1 for the tax period, and the flow reaches the distributors’ GSTR-2B on the next auto-population cycle.
For the balance 3,580 invoices in the 22-30 September range with both invoice date and dispatch date post-cutover, the rate of 5 percent was applied on the original invoice and no straddle-window correction is required. This group is the “clean” cohort and only enters the straddle-reconciliation pack as a control-total line.
Common reconciliation breakages
Five breakages recur across the pharma channel at the 22-September-2025 straddle window, and each maps to a specific control failure.
-
Dispatch date not captured or captured incorrectly on the invoice register. The formulator’s ERP records the invoice date but often does not carry the transporter’s lorry-receipt-time or the e-way bill dispatch stamp. Without the dispatch date, Section 14 classification degrades to a guess based on invoice date alone, and the Clause (a) versus Clause (b) call is wrong on any invoice where the dispatch was deferred beyond invoice generation. The reconciliation control is to ingest the e-way bill portal extract by invoice reference and cross-key the actual dispatch stamp against the invoice.
-
Section 34 credit note issued in the wrong GSTR-1 period. The Section 34 credit note must be reported in the GSTR-1 for the period in which it was issued, and the recipient’s GSTR-2B auto-populates accordingly. Formulators that batch credit-note issuance to the following month or quarter push the reduction to a later distributor GSTR-2B cycle, breaking the one-to-one correspondence with the original invoice’s ITC claim period. This creates a temporary ITC overclaim at the distributor and a Section 74 exposure at the next scrutiny.
-
Fresh invoice at the corrected rate not issued alongside the credit note. Some formulators issue only the credit note (correcting the tax) but do not issue the fresh invoice at the new rate, leaving the transaction under-invoiced. The distributor cannot claim ITC at the new rate without a fresh invoice, and the supplier under-reports output GST relative to the actual taxable supply value. The reconciliation control is a one-to-one pairing rule: every Section 34 credit note issued in the straddle window must have a matching fresh invoice at the corrected rate for the same base value.
-
Distributor’s ITC reversal register not maintained. Distributors who claim ITC at 12 percent from the auto-populated GSTR-2B without cross-checking the Section 14 position expose themselves to a Section 73 or Section 74 demand for the excess 7 percentage points on any invoice where Clause (b)(i) actually applies. The reversal register — keyed to invoice, dispatch date, receipt date, and Section 14 clause — is the audit-defensible workbook that closes this gap.
-
Section 65 audit walk fails because of missing per-invoice audit trail. A subsequent audit walk of the straddle window collapses if the formulator cannot produce, per invoice, the original invoice, the Section 14 classification worksheet, the Section 34 credit note (if any), the fresh invoice (if any), and the recipient’s confirmation of ITC reversal or adjustment. This is a documentation discipline problem, not a substantive one, but it consistently causes protracted audit closures and unnecessary Section 73 notices. The reconciliation playbook for monthly close sets out the audit-trail template that closes this gap.
How a reconciliation platform handles this
A purpose-built pharma reconciliation platform ingests the formulator’s ERP invoice register, the CBIC e-way bill portal extract keyed on invoice reference, the distributor’s goods-received-note feed for the shipping window, the GSTR-1 upload and GSTR-2B download feeds for both sides, and produces a per-invoice straddle-window reconciliation pack for the 21-30 September 2025 pipeline. The platform anchors each invoice’s supply date to the dispatch stamp on the e-way bill, classifies the invoice against Section 14’s six clauses mechanically, generates the Section 34 credit-note issuance schedule for every invoice where the applicable rate diverges from the rate charged, pairs each credit note with a fresh invoice at the corrected rate for the same base value, and reconciles the credit-note flow through the supplier’s GSTR-1 into the recipient distributor’s GSTR-2B. On the distributor side, the platform maintains the ITC reversal register with the applicable rate cap, the Section 14 clause governing each invoice, and any GSTR-2B versus GSTR-3B differential requiring supplier follow-up. Match rate improvement of 51 to 88 percent on the straddle-window reconciliation chain, combined with an ISO 27001:2022 posture and DPDP Act 2023 aligned data handling, is what makes the platform an infrastructure investment for an Indian pharma formulator rather than a spreadsheet substitute at a rate-transition inflection point.
Cross-cluster bridges and where to read next
The Section 14 discipline in this article sets up the reconciliation base for every rate-transition inflection point in Indian GST, not just the pharma-specific 22-September-2025 cutover. For the parallel scenario at the pharma stockist and distributor level — where opening stock at 22-September-2025 was carried at 12 percent and must be reconciled against outward sales at 5 percent — read the pharma inventory GST rate switch reconciliation walkthrough. For the definitional GSTR-2B cross-reference that a distributor’s ITC reversal register ultimately reconciles against, the GSTR-2B ITC reconciliation failure modes cornerstone unpacks the auto-population and matching mechanics. For a related straddle-invoice mechanic in an entirely different sector — the edible oil Chapter 15 blocked-refund cycle under Notification 09/2022 — the edible oil Chapter 15 IDR refund blocked walkthrough shows the same underlying pattern (regulatory cutover creates a reconciliation surface that the ERP does not natively carry). For the methodology framework that Terra Insight applies to every reconciliation cluster — including the pharma straddle-window pack — read the reconciliation failure mode analysis pillar. The commercial anchor for the entire pharma sub-cluster is Pharma reconciliation software India; the broader authority is reconciliation software India.
The five FAQs below address the operational questions Indian pharma finance controllers and distributor tax leads ask most often when closing the 21-30 September 2025 straddle-invoice window.
Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →
- ▸ Section 14, Central Goods and Services Tax Act 2017 — Change in rate of tax in respect of supply of goods or services. Notwithstanding anything contained in Section 12 or Section 13, the time of supply where there is a change in the rate of tax is determined per the six-clause bifurcation of Section 14 — (a)(i), (a)(ii), (a)(iii) where the supply was made BEFORE the rate change, and (b)(i), (b)(ii), (b)(iii) where the supply was made AFTER the rate change. Each clause fixes the time of supply as the date of invoice, the date of payment, or the earlier of the two, and therefore the applicable rate.
- ▸ Section 34, Central Goods and Services Tax Act 2017 — Credit notes and debit notes. Where a tax invoice has been issued and the taxable value or tax charged in that invoice is found to exceed the taxable value or tax payable in respect of that supply, the registered person may issue a credit note in the prescribed form. The credit note reduces the supplier's output tax liability and the recipient's input tax credit for the same amount, with the adjustment reflected in the GSTR-1 (supplier) and GSTR-2B (recipient) for the relevant tax period. The Section 34 window closes on 30 November of the following financial year or the date of annual return, whichever is earlier.
- ▸ 56th GST Council recommendations, 3 September 2025 (effective 22 September 2025) — Rate rationalisation for the pharmaceutical sector — all drugs (medicaments and formulations) moved to 5 percent flat, medical devices under HSN 9018 to 9022 moved from 18 percent to 5 percent, and life-saving drugs (specified schedule covering cancer, HIV, TB, and rare-disease therapies) moved to nil rate. The transition raises the Section 14 time-of-supply question for every invoice issued in the 21-30 September 2025 pipeline window where the invoice date, dispatch date, and receipt date straddle the cutover.
- ▸ GST Council FAQ, 3 September 2025 (56th meeting) — Question 10 addresses the applicability of the rate change to invoices issued before 22 September 2025 where goods are received after the cutover. Question 25 addresses stock-in-hand reconciliation for distributors and stockists as at the cutover date. Question 51 addresses the Section 54(3) inverted-duty refund cycle deepened by the flat 5 percent output structure against 18 percent input on packaging and non-drug supplies.
- ▸ HSN Chapter 30 (Pharmaceutical Products), CGST rate schedule — HSN 3003 covers non-formulation drugs and bulk drug mixtures. HSN 3004 covers medicaments in measured doses for retail sale — the finished-formulation SKU that a formulator such as Aurobindo Pharma Unit-IV dispatches to distribution partners under a standard invoice. Pre-22 September 2025 rate: 12 percent (excluding scheduled life-saving drugs at 5 percent or nil). Post-22 September 2025 rate: 5 percent flat, with the specified life-saving-drug schedule at nil.
- ▸ Section 31 read with Rule 46, Central Goods and Services Tax Rules 2017 — Invoicing requirements — Section 31 obliges a registered person to issue a tax invoice showing the description, quantity, value of supply, rate and amount of tax, and other prescribed particulars before or at the time of removal of goods. Rule 46 prescribes the invoice fields including the HSN code, the rate of tax, and the amount of tax charged. Read together, they anchor the technical distinction between dispatch date, invoice date, and receipt date that Section 14 relies on to fix time of supply at the rate cutover.